Economic evaluation of breast cancer test-treatment strategies using OncotypeDX – preliminary results of a modeling study

Beate Jahn, Ursula Rochau, Christina Kurzthaler, Marjan Arvandi, Kim Saverno, Felicitas Kühne, Martina Kluibenschädl, Murray Krahn, Mike Paulden & Uwe Siebert
Objectives: Breast cancer is the most common malignant disease in Western women. At the ONCOTYROL research center, a Breast Cancer Outcomes & Policy model was developed to evaluate the cost effectiveness of personalized test-treatment strategies in the Austrian context. The goal of this study [for full text, please go to the a.m. URL]